Procurement of UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets

A Contract Award Notice
by BELFAST HEALTH AND SOCIAL CARE TRUST

Source: Find a Tender
Type: Contract (Goods)
Duration: not specified
Value: £250K

Sector: HEALTH
Published: 28 Oct 2022
Delivery: not specified
Deadline: n/a

Concepts

Location

Northern Ireland: Belfast Health and Social Care Trust

Geochart for 1 buyers and 1 suppliers

1 buyer

Belfast Health & Social Care Trust Belfast

1 supplier

Sciensus Pharma Services Burton on Trent

Description

Procurement of UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets Patent Protected Medicines

Total Quantity or Scope

UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets, Patent Protected Medicines

Award Detail

1	Sciensus Pharma Services (Burton on Trent) Procurement of UPADACITINIB (RINVOQ) HOMECARE 15 mg Modified-Release Tablets Reference: 030566-2022-dacpm2022-40-1 Value: £250,000

Award Criteria

price

CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

Legal Justification

These essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.